Prosight Management, LP Axogen, Inc. Transaction History

Prosight Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $3.06 Million - $4.63 Million	-209,088 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $2.26 Million - $5.06 Million	132,347 Added 172.46%	209,088 $4.27 Million
Q3 2018 Nov 15, 2018	BUY	$34.05 - $55.9 $2.61 Million - $4.29 Million	76,741 New	76,741 $2.83 Million

180

36.4M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $767M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.